
    
      This is a non-randomized feasibility study that will enroll up to 50 participants that have
      undergone a previous autonomic reflect screen (ARS) assessment and were either diagnosed with
      OH or reflex syncope, or considered to be control subjects for this study.

      A maximum of 20 subjects diagnosed with reflex syncope, a maximum of 10 subjects diagnosed
      with OH and a maximum of 10 control subjects will be enrolled. There will be one study visit
      per subject.
    
  